Howdy Folks: I have read the documents in the 8-K. I

New Post Public Reply Private Reply Replies (5) Message Board
Snark
923
Howdy Folks:

I have read the documents in the 8-K. I have a few observations I can offer. How the moving parts come together to a form a unified construct from my perspective. There are several things that leap out at me in particular.

I suppose the first observation deals with the comparative relationship between the two companies going forward given that Steve is assigning a 51% voting interest to Pasaca. When I read this it is clear that the construct uniting the two companies is not about control. It is about uniting two highly successful creative juggernauts into a single engine of creativity and enterprise.

In support of that, everything about the construct is designed to preserve and retain the comparative independence and autonomy of the two corporate entities. Stepping back and thinking about it you can see why the two principals — Steve at QMC and Dr. Charles Huang at Pasaca — would want that. The idea would be to preserve intact what each is good at while creating the framework for synergies to occur. The breadth of diagnostic applications and global reach of Innova is incomparable; QMC is the absolute leader in the application of quantum dot technology to diverse applications. Neither would want to compromise or dilute what has made each successful while uniting them together in the common pursuit of joint applications.

Following from that, the third observation deals with the comparative private/public status of the two entities going forward, given the majority interest of the private entity. Is there any reason to think that the private status of Pasaca would come to dominate over the two? The answer is unequivocally “no”. Everything in the documents is explicitly contrary to such a notion. What follows is my understanding of the structure of the agreement and how it addresses these three points.

In his cover statement, Steve states: “To join Pasaca Capital, as a portfolio company, represents a tremendous opportunity to enhance our QMC HealthID™ offering, to accelerate our COVID-19 work with Innova Medical Group Inc. and to expand the use of quantum dot technology to advance diagnostics in a broad range of disease states. Together, we’re working to bring greater precision, personalization and access to healthcare.”

QMC will become a member of the Pasaca portfolio be selling them a majority interest in QMC. Beyond that, QMC will retain its status as an independent and separate corporate entity. QMC shareholders will retain their shares (diluted as a proportion of ownership by 51%). Item two of the Distribution Agreement (Exhibit 10-4) is explicit on this point:

"Status as Independent Contractor. Pasaca and any Designees are independent contractors pursuant to this Agreement. Nothing in this Agreement creates any agency, joint venture, partnership, or other form of joint enterprise, employment, or fiduciary relationship between the Parties. Neither Party has any express or implied right or authority to assume or create any obligations on behalf of or in the name of the other Party or to bind the other Party to any contract, agreement, or undertaking with any third party. Pasaca and any Designees shall be solely responsible for any and all costs or expenses that it may incur in the performance of its obligations hereunder."

The Registration Rights Agreement, Exhibit 10-3, operationalizes their mutual independence by defining the terms by which Pasaca ownership in QMC is handled through the assignment of QMC shares. There was something curious about Section Three, Subsection k. It seems to obligate QMC to listing its shares on the NY Stock Exchange or NASDAQ Stock Market right out of the gate. Is there an implicit expectation of up-listing as a condition of the agreement? That would seem to imply the immediate explosion of revenue to QMC following upon this agreement.

"k) The Company shall use its best efforts to (i) cause the Initial Date to occur on or before March 31, 2021, (ii) cause the Common Stock to be listed on the New York Stock Exchange or on the NASDAQ Stock Market and to remain eligible for trading thereon, (iii) cause all the Registrable Securities covered by a Registration Statement to be listed on each securities exchange on which securities of the same class or series issued by the Company are listed,..."

In terms of the structure of overall agreement, the areas of mutual obligation and overlap occur at the intersection of Pasaca’s Subsidiary Innova Medical Group and QMC’s Subsidiary QMC Health ID. As outlined in the Distribution Agreement, Item 11, each side retains the rights to its own intellectual property. In practical terms, Pasaca's majority ownership in QMC is expressed by assignment of a subset of Pasaca members to the QMC Board of Directors.

Otherwise, while it is not stated as such, all of the parallel sub-entities and activities of QMC as described in Section A of the Securities Purchase and Finance Agreement (Exhibit 10-1) will remain the prerogative of QMC to manage and operate.* As majority owner, and via its membership on the QMC Board of Directors, Pasaca will exercise managerial oversight and guidance, if not joint direction.

With this new capitalization and access to all that Pasaca offers via its Innova Capital Group this seems like a decided win for QMC and its shareholders. I am especially impressed by the dynamic picture it paints. Initial collaboration will occur around Innova, branching out to the entire spectrum of applications of quantum dots to medical diagnostics. Everything else that Steve has put in play will continue on, with capitalization and involvement by Pasaco as appropriate. It seems like the Pasaca team, particularly Dr. Charles Huang as its head, is a good fit for Steve in terms of their mutual entrepreneurialism, business skills, facility for cutting edge technology, and drive.

I guess the way Steve looks at this is that the revenue opportunity as represented by our joint actives with Innova will be of such magnitude so as to off-set the dilution of income by 51%, say if we were to contract with Innova for the marketing of our products as a client. It was a strategic calculation, made with the understanding of what is best for shareholders, all things considered. It is easy to see how this calculus works. From Steve’s standpoint, half of something is better than all of nothing (granting that some income to QMC was already beginning to accrue). Given the horsepower that Pasaca brings to the party, it is not a reach to see how this will work to the benefit of QMC shareholders.

As a concluding thought, when I read the documents in the 8-K, I am struck by the singular vision of the construct. From start to finish as you walk through Exhibits 1-4 the message is sharp, focused, and internally consistent throughout. When Steve and Dr. Huang sat down to work this out there was no space between them in their understanding of how this would work. It is an impressive statement of purpose as a joint construct. It is a solid foundation for moving forward.

That is my take on the documents that comprise the agreement. I certainly welcome any revisions if some of this doesn’t seem right.

*I was really impressed by the succinct description of QMC sub-entities and activities contained at the front of the Securities Purchase and Finance Agreement (Exhibit 10-1). I will append that here because it is so good.

A. The Company, through its wholly owned subsidiaries, Solterra Renewable Technologies, Inc. and QMC HealthID Incorporated, specializes in the design, development, production and supply of quantum dots, including tetrapod quantum dots, a high-performance variant of quantum dots, and highly uniform nanoparticles, using its patented automated continuous flow production process, and integrating the quantum dots in various applications and solutions. The Company, through its acquisition of the intangible assets of Capstan Platform, Inc., is involved in distributed ledger technology, DLT or blockchain technology, solutions for business enterprises. The Company, through its patent-pending QMC™ DLT platform, combined with its quantum dot production process, has a technology to track goods end-to-end in supply chains, from manufacture to retail point of sale, addressing counterfeit, product liability and other product-track and -trace issues. Through its QMC™ HealthID product, the Company provides end-to-end visibility to support testing and immunization for infectious diseases. The foregoing business segments are referred to herein collectively as the “Business.”

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 0

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 110

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
HONOR Leads in China, Eyes Middle East Market

Updated Category News Views 23

A Force to be Reckoned With Talk about making waves—HONOR's got the bragging rights now. Sitting pretty at the top among Android smartphone brands in China ain't no small feat. We're looking at a snazzy 12.04% market share for October 2026, all thanks to selling a cool 2.573 million units. The kicker? This ain't even their full potential. They're hustling hard in the...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 258

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 102

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 38

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 63

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 41

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 106

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Into Guess?, Inc.: Are Fiduciary Duties at Risk?

Updated Category News Views 121

Introduction to the Investigation Recently, a significant issue has arisen concerning Guess?, Inc. (NYSE: GES) and its handling of a pending merger with Authentic Brands Group LLC. This acquisition deal, valued at $16.75 per share, has prompted a legal investigation to determine whether the company's board of directors and top executives may have breached their fiduciary...

Continue Reading
Count Down to Class Action: Important News for GO Investors

Updated Category News Views 281

Important Deadline for Grocery Outlet Holding Corp. Investors As the deadline for the class action lawsuit approaches for Grocery Outlet Holding Corp. (NASDAQ: GO), investors are urged to pay close attention. The law firm Kessler Topaz Meltzer & Check, LLP has announced that investors who purchased or acquired Grocery Outlet securities from November 7, 2023, to May 7,...

Continue Reading
Discover KLIMB Jr.: The Latest in Pet Training Innovation

Updated Category News Views 239

Introducing the KLIMB Jr. by Blue-9 Pet Products Blue-9 Pet Products has made a remarkable stride in pet care with the introduction of the KLIMB Jr., a compact and versatile training platform for dogs and cats. This innovative product serves as a perfect tool for pet owners aiming to enhance their pets’ training and daily enrichment activities. A Tailored Solution for...

Continue Reading
Elsevier, Lancet Awards Highlight Community Health Impact

Updated Category News Views 62

Pioneering Health Awards Make Waves Amidst our swirling universe of breakthroughs and challenges, three research teams just snagged the spotlight. Recognized by the Elsevier Foundation and The Lancet in their first-ever Evidence to Impact Awards. These folks aren't just scribbling in labs—they're rolling up their sleeves and getting those much-needed health solutions...

Continue Reading
k-ID's Kai SDK: Age-Adaptive Design Revolution

Updated Category News Views 139

New Horizons for Developers Today, if you're building an app, you're just as likely to be wrangling with legal regulations as you are writing code. That's where k-ID’s new SDK, Kai, comes into play—it's not just another tool in the shed, it’s the whole toolbox for dealing with age-specific app requirements everywhere. The Changing App Landscape Why does this matter?...

Continue Reading